210 related articles for article (PubMed ID: 16193096)
1. Insulin glulisine.
Cox SL
Drugs Today (Barc); 2005 Jul; 41(7):433-40. PubMed ID: 16193096
[TBL] [Abstract][Full Text] [Related]
2. Inhaled human insulin.
Strack TR
Drugs Today (Barc); 2006 Apr; 42(4):207-21. PubMed ID: 16703118
[TBL] [Abstract][Full Text] [Related]
3. Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.
Ulrich H; Snyder B; Garg SK
Vasc Health Risk Manag; 2007; 3(3):245-54. PubMed ID: 17703632
[TBL] [Abstract][Full Text] [Related]
4. Insulin glulisine: a review of its use in the management of diabetes mellitus.
Garnock-Jones KP; Plosker GL
Drugs; 2009 May; 69(8):1035-57. PubMed ID: 19496630
[TBL] [Abstract][Full Text] [Related]
5. Insulin lispro: its role in the treatment of diabetes mellitus.
Campbell RK; Campbell LK; White JR
Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics and pharmacodynamics of insulin glulisine.
Becker RH; Frick AD
Clin Pharmacokinet; 2008; 47(1):7-20. PubMed ID: 18076215
[TBL] [Abstract][Full Text] [Related]
7. Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes.
Garg SK; Ellis SL; Ulrich H
Expert Opin Pharmacother; 2005 Apr; 6(4):643-51. PubMed ID: 15934890
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes.
Danne T; Becker RH; Heise T; Bittner C; Frick AD; Rave K
Diabetes Care; 2005 Sep; 28(9):2100-5. PubMed ID: 16123473
[TBL] [Abstract][Full Text] [Related]
9. Insulin glulisine.
Robinson DM; Wellington K
Drugs; 2006; 66(6):861-9. PubMed ID: 16706558
[TBL] [Abstract][Full Text] [Related]
10. Insulin aspart: a review.
Owens D; Vora J
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
[TBL] [Abstract][Full Text] [Related]
11. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
[TBL] [Abstract][Full Text] [Related]
12. Insulin glulisine. Aventis Pharma.
Barlocco D
Curr Opin Investig Drugs; 2003 Oct; 4(10):1240-4. PubMed ID: 14649217
[TBL] [Abstract][Full Text] [Related]
13. Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus.
Miles HL; Acerini CL
Paediatr Drugs; 2008; 10(3):163-76. PubMed ID: 18454569
[TBL] [Abstract][Full Text] [Related]
14. Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects.
Becker RH; Frick AD; Burger F; Potgieter JH; Scholtz H
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):435-43. PubMed ID: 16151977
[TBL] [Abstract][Full Text] [Related]
15. Biosynthetic Human Insulin and Insulin Analogs.
Rodbard HW; Rodbard D
Am J Ther; 2020; 27(1):e42-e51. PubMed ID: 31876563
[TBL] [Abstract][Full Text] [Related]
16. Insulin lispro: a review of its use in the management of diabetes mellitus.
Simpson D; McCormack PL; Keating GM; Lyseng-Williamson KA
Drugs; 2007; 67(3):407-34. PubMed ID: 17335298
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences.
Home PD
Diabetes Obes Metab; 2012 Sep; 14(9):780-8. PubMed ID: 22321739
[TBL] [Abstract][Full Text] [Related]
18. Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.
Umpierrez GE; Jones S; Smiley D; Mulligan P; Keyler T; Temponi A; Semakula C; Umpierrez D; Peng L; Cerón M; Robalino G
Diabetes Care; 2009 Jul; 32(7):1164-9. PubMed ID: 19366972
[TBL] [Abstract][Full Text] [Related]
19. Insulin glulisine: an evaluation of its pharmacodynamic properties and clinical application.
Helms KL; Kelley KW
Ann Pharmacother; 2009 Apr; 43(4):658-68. PubMed ID: 19336657
[TBL] [Abstract][Full Text] [Related]
20. Insulin glulisine: aspects of basal/bolus therapy for optimized treatment of diabetes mellitus.
Iltz JL
Expert Opin Biol Ther; 2009 Mar; 9(3):369-75. PubMed ID: 19216625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
